Search

Search results

84 results found

The specificity of heterophil antibodies in patients and healthy donors with no or minimal signs of infectious mononucleosis.

Publication: Journal Article

Horwitz, C A, W Henle, G Henle, H Polesky, H Wexler, and P Ward. 1976. “The Specificity of Heterophil Antibodies in Patients and Healthy Donors With No or Minimal Signs of Infectious Mononucleosis.”. Blood 47 (1): 91-8.

[Changes in the indicators of immunologic reactivity in patients with juvenile uterine hemorrhages in different methods of therapy].

Publication: Journal Article

Poliak, Sh. 1975. “[Changes in the Indicators of Immunologic Reactivity in Patients With Juvenile Uterine Hemorrhages in Different Methods of Therapy].”. Akusherstvo I Ginekologiia, no. 10: 29-31.

The specificity of heterophil antibodies in patients and healthy donors with no or minimal signs of infectious mononucleosis.

Publication: Journal Article

Solomon finished his internship at our lab!

News: August 23, 2024

Solomon completed his summer internship at our lab. Over the last three months, he has proved that he is an outstanding young scientist. We greatly appreciate Solomon's contribution to our drug discovery effort and wish him the best of luck in his future endeavors.

Mitochondrial control of glycerolipid synthesis by a PEP shuttle.

Publication: Journal Article

Yamamuro, Tadashi, Daisuke Katoh, Guilherme Martins Silva, Hiroshi Nishida, Satoshi Oikawa, Yusuke Higuchi, Dandan Wang, et al. 2026. “Mitochondrial Control of Glycerolipid Synthesis by a PEP Shuttle.”. BioRxiv : The Preprint Server for Biology.

Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.

Publication: Journal Article

Cheong, Jae Eun, and Lijun Sun. 2018. “Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.”. Trends in Pharmacological Sciences 39 (3): 307-25.

A patent review of IDO1 inhibitors for cancer.

Publication: Journal Article

Cheong, Jae Eun, Anil Ekkati, and Lijun Sun. 2018. “A Patent Review of IDO1 Inhibitors for Cancer.”. Expert Opinion on Therapeutic Patents 28 (4): 317-30.

A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasis.

Publication: Journal Article

Wong, Daniel J, Diane D Park, Simon S Park, Carolyn A Haller, Jiaxuan Chen, Erbin Dai, Liying Liu, et al. 2021. “A PSGL-1 Glycomimetic Reduces Thrombus Burden Without Affecting Hemostasis.”. Blood 138 (13): 1182-93.

Eleifend quam adipiscing vitae proin sagittis nisl rhoncus mattis

Blog: May 08, 2024

Nisl pretium fusce id velit ut tortor pretium viverra suspendisse. Urna porttitor rhoncus dolor purus non enim praesent elementum. Felis donec et odio pellentesque diam volutpat commodo sed. Hic rerum possimus accusamus velit qui alias quia sit ipsa. Aspernatur qui dolores qui quod qui eos quas...

About

Page